Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of GSK1362885 in healthy volunteers completed. Type 2 diabetes mellitus is listed as a condition in the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK1362885

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED